(Q37032646)

17 August 2017

1 reference

title

Current use and development of vaccines for Japanese encephalitis (English)

1 reference

Japanese encephalitis virus

17 August 2017

main subject

0 references

1

David W C Beasley

1 reference

17 August 2017

Penny Lewthwaite

2

1 reference

17 August 2017

Tom Solomon

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

95-106

1 reference

17 August 2017

cites work

Flavivirus encephalitis.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

21 January 2018

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunization against Japanese encephalitis in China: a policy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Encephalitis outbreak finds Indian officials unprepared

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Japanese Encephalitis Outbreak, India, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Molecular epidemiological analysis of Japanese encephalitis virus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Comparison of structural proteins among antigenically different Japanese encephalitis virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Antigenic analysis of Japanese encephalitis viruses in Asia by using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Genetic variation of Japanese encephalitis virus in nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Duration of neutralizing antibody titer after Japanese encephalitis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: Biological properties in the mouse model of neuroinvasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Japanese encephalitis: development of new candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Development of an effective Japanese encephalitis virus-specific DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.95

21 January 2018

Identifiers

DOI

10.1517/14712598.8.1.95

1 reference

17 August 2017

1 reference